PATENT CLAIM ANALYSIS

Application Number: 15755399
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["530", "345000"]

Abstract:
The present invention is directed towards methods for treating non-alcoholic fatty liver disease (NAFLD) in a patient and determining prognosis of NAFLD in a patient.

Claim (Index 9):
The method of  claim 8 , wherein the activity of metabolic and/or signaling pathways are identified as abnormal by the difference in the percent post-translational modification (% PTM) of a protein, expressed in one form by, but not limited to, the ratio of the area under the curve (AUC) of total post-translational modified protein to the AUC of total protein (modified and unmodified), that varies from normal by 10% of one or more pathway proteins.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 88.0
- Lexical Diversity: 1.16667
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14778379', '14777001', '13157977', '15032508', '13178986']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6850848150806147
- 35 USC 102 Novelty (BERT): 0.517382424550766
- Combined Prediction Score: 0.6683145760276299
- Mean Citation Score: 252.559652
- Max Citation Score: 285.673
- Similarity Product: 174.87844277280567

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test